We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbAurobindo Pharma Ltd Share Price
breadcrumbResults

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR
Revenue
₹ 8.39K+10.73% from last year
Operating profits
₹ 1.93K+6.54% from last year
Net income
₹ 935.02+1.63% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009
Net worth29842.8026839.8524575.9821929.8716824.6713890.7811680.429371.917287.305155.913750.152605.762339.652444.831829.081241.26
Fixed assets14492.7911023.6910532.099373.589396.478474.856520.684833.784179.693705.642721.672638.872194.651738.601710.851398.77
Debt6315.224861.522372.774972.275561.976966.764769.933364.145041.074451.073769.143435.463095.942414.252154.562332.97
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012FY2011FY2010FY2009
Operating2434.522386.755016.483329.054381.281650.971954.523278.581419.761236.81646.28274.87326.25335.11425.18136.03
Investing -4255.95-3977.75-3211.56598.69-1567.64-2902.59-1926.59-1787.04-1445.21-1397.97-818.74-246.34-563.16-599.07-399.02-406.28
Financing 800.421814.41-2969.27-1364.94-1947.181919.06864.15-1915.26365.4493.21117.64108.09118.85406.98-84.04164.99

Financial ratios

Profitability ratiosinfo2
ROA7.63%
ROE11.18%
ROCE13.76%
EPS54.16%
Net profit margin10.93%
Operating profit margin10.71%
Dividend per share4.5%
Operational ratiosinfo2
Quick ratio1.14%
Current ratio1.95%
Interest coverage16.12%
Assets turnover1.44%
Debt to equity0.21%
Valuation ratiosinfo2
P/E ratio19.19%
P/B ratio2.05%
Dividend yield
EV/EBITDA
Aurobindo Pharma Limited continues to be one of the world’s fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and capabilities in various therapeutic domains. Its API business has ensured the profitability and growth of its formulations business through seamless vertical integration. Its API business is supported by technologically advanced research and development infrastructure, which develops new products and plays a role in the delivery of products to the market. It has built a strong presence in key therapeutic segments such as Central nervous system (CNS), cardiovascular (CVS), anti-retroviral (ARV), anti-diabetics, gastroenterology and antibiotics. Also, it is building a diversified pipeline in high-margin specialty generic formulations segment.
personal

Grow your wealth with more research recommendations

+91